Skip to main content
Log in

Selective screening for inborn errors of metabolism on clinical patients using tandem mass spectrometry in China: A four-year report

  • Neonatal Screening
  • Published:
Journal of Inherited Metabolic Disease

Summary

We have initiated clinical selective screening for inborn errors of metabolism in China by analysing amino acids and acylcarnitines in a dried blood filter-paper samples using tandem mass spectrometry. Samples from a total of 3070 children suspected of inborn errors of metabolism were collected through a study network which covered most provinces of China. The diagnoses were further confirmed through clinical symptoms, by gas chromatography–mass spectrometry and other biochemistry studies, and in a few cases by DNA analysis. In all, 212 cases were diagnosed (6.6%) including 92 (43.4%) with amino acids disorders (48 with phenylketonuria, 12 with ornithine carbamoyltransferase deficiency, 7 with tyrosinaemia type I, 9 with maple syrup urine disease, 5 with citrullinaemia type I, 8 with citrullinaemia type II, 2 with homocystinuria, and 1 with argininaemia); 107 (50.5%) with organic acid disorders (including 58 with methylmalonic acidaemia, 13 with propionic acidaemia, 6 with isovaleric acidaemia, 7 with glutaric acidaemia type I, 6 with 3-methylcrotonyl-CoA carboxylase deficiency, 2 with 3-hydroxy-3-methylglutaryl-CoA lyase deficiency, 10 with multiple carboxylase deficiency, and 5 with β-ketothiolase deficiency); and 13 (6.1%) with fatty acid oxidation disorders (including 1 with carnitine palmitoyltransferase deficiency type I, 1 with carnitine palmitoyltransferase deficiency type II, 1 with short-chain acyl-CoA dehydrogenase deficiency, 5 with medium-chain acyl-CoA dehydrogenase deficiency, 3 with very long-chain acyl-CoA dehydrogenase deficiency, and 2 with multiple acyl-CoA dehydrogenase deficiency). It is suggested that tandem mass spectrometry is useful for selective screening of clinically suspected patients. The majority of diseases (94%) in this study were amino acid disorders and organic acid disorders. Fatty acid oxidation disorders are relatively rare in the Chinese, but medium-chain acyl-CoA dehydrogenase deficiency should be further investigated.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Allardaa P, Grenierb A, Korson MS, et al (2004) Newborn screening for hepatorenal tyrosinemia by tandem mass spectrometry: analysis of succinylacetone extracted from dried blood spots. Clin Biochem 37: 1010–1015.

    Article  Google Scholar 

  • Chace DH, DiPerna JC, Kalas TA, et al (2001) Rapid diagnosis of methylmalonic and propionic acidemias: quantitive tandem mass spectrometry analysis of propionylcarnitine in filter-paper blood specimens obtained from newborns. Clin Chem 47: 2040–2044.

    PubMed  CAS  Google Scholar 

  • Chace DH, Kalas TA (2005) A biochemical perspective on the use of tandem mass spectrometry for newborn screening and clinical testing. Clin Biochem 38: 296–309.

    Article  PubMed  CAS  Google Scholar 

  • Dott M, Chace D, Fierro M, et al (2006) Metabolic disorders detectable by tandem mass spectrometry and unexpected early childhood mortality: a population-based study. Am J Med Genet 140A: 837–842.

    Article  Google Scholar 

  • Frazier DM, Millington DS, McCandless SE, et al (2006) The tandem mass spectrometry newborn screening experience in North Carolina: 1997–2005. J Inherit Metab Dis 29: 76–85.

    Article  PubMed  CAS  Google Scholar 

  • Hoffmann GF, Kries R, Klose D, et al (2004) Frequencies of inherited organic acidurias and disorders of mitochondrial fatty acid transport and oxidation in Germany. Eur J Pediatr 163: 76–80.

    Article  PubMed  CAS  Google Scholar 

  • Maier EM, Liebl B, Roschinger W, et al (2005) Population spectrum of ACADM genotypes correlated to biochemical phenotypes in newborn screening for medium-chain acyl-CoA dehydrogenase deficiency. Hum Mutat 25: 443–452.

    Article  PubMed  CAS  Google Scholar 

  • Pasquali M, Monsen G, Richardson L (2006) Biochemical findings in common inborn errors of metabolism. Am J Med Genet Part C 142C: 64–76.

    Article  CAS  Google Scholar 

  • Saudubray JM, Sedel F, Walter JH (2006) Clinical approach to treatable inborn metabolic disorders: an introduction. J Inherit Metab Dis 29: 261–274.

    Article  PubMed  Google Scholar 

  • Schulze A, Lindner M, Kohlmuller D, et al (2003) Expanded newborn screening for inborn errors of metabolism by electrospray ionization-tandem mass spectrometry: results, outcome, and implications. Pediatrics 111: 1399–1406.

    Article  PubMed  Google Scholar 

  • Shigematsu Y, Hirano S, Hata I, et al (2002) Newborn mass screening and selective screening using elctrospray tandem mass spectrometry in Japan. J Chromatogr B 776: 39–48.

    Article  CAS  Google Scholar 

  • Wajner M, Raymond K, Barschak A, et al (2002) Detection of organic acidemias in Brazil. Arch Med Res 33: 581–585.

    Article  PubMed  Google Scholar 

  • Xuefan Gu, Lianshu Han, Xiaolan Gao, et al (2004) A pilot study of selective screening in high risk children with inborn error of metabolism using tandem mass spectrometry. Chin J Pediatr 42: 401–404.

    Google Scholar 

  • Yang YL, Songn F, Qian N, et al ( 2005) Clinical and laboratory screening studies on urea cycle defects. Chin J Pediatr 45: 331–334.

    Google Scholar 

  • Yoon HR, Lee KR, Kang S, et al (2005) Screening of newborns and high-risk group of children for inborn metabolic disorders using tandem mass spectrometry in South Korea: a three-year report. Clin Chim Acta 354: 167–180.

    Article  PubMed  CAS  Google Scholar 

  • Zytkovicz TH, Fitzgerald EF, Marsden D, et al (2001) Tandem mass spectrometry analysis for amino, organic, and fatty acid disorders in newborn dried blood spots: a two-year summary from the New England Newborn Screening Program. Clin Chem 47: 1945–1955.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to X. F. Gu.

Additional information

Communicating editor: Rodney Pollitt

Competing interests: None declared

References to electronic databases: Propionic acidemia (OMIM 606054); very long-chain acyl-CoA dehydrogenase deficiency (OMIM 201475); medium-chain acyl-CoA dehydrogenase deficiency (OMIM 201450); ornithine transcarbamylase deficiency (OMIM 300461); maple syrup urine disease (OMIM 248600); tyrosinaemia type I (OMIM 276700); citrullinaemia type II (OMIM 603471); multiple carboxylase deficiency, very long-chain acyl-CoA dehydrogenase deficiency (OMIM 201475); medium-chain acyl-CoA dehydrogenase deficiency (OMIM 201450)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Han, L.S., Ye, J., Qiu, W.J. et al. Selective screening for inborn errors of metabolism on clinical patients using tandem mass spectrometry in China: A four-year report. J Inherit Metab Dis 30, 507–514 (2007). https://doi.org/10.1007/s10545-007-0543-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10545-007-0543-9

Keywords

Navigation